Reata Pharmaceuticals Buy Hold or Sell Recommendation
| RETADelisted Stock | USD 172.36 0.02 0.01% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Reata Pharmaceuticals is 'Not Rated'. Macroaxis provides Reata Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding RETA positions. The advice algorithm takes into account all of Reata Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Reata Pharmaceuticals' buy or sell advice are summarized below:
Real Value 131.55 | Hype Value 172.36 | Market Value 172.36 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Reata Pharmaceuticals given historical horizon and risk tolerance towards Reata Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Reata Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
Reata |
Execute Reata Pharmaceuticals Buy or Sell Advice
The Reata recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Reata Pharmaceuticals. Macroaxis does not own or have any residual interests in Reata Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Reata Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Reata Pharmaceuticals Trading Alerts and Improvement Suggestions
| Reata Pharmaceuticals is not yet fully synchronised with the market data | |
| Reata Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.22 M. Net Loss for the year was (311.9 M) with loss before overhead, payroll, taxes, and interest of (167.63 M). | |
| Reata Pharmaceuticals currently holds about 481.47 M in cash with (204.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.19. | |
| Over 88.0% of the company shares are owned by institutional investors |
Reata Pharmaceuticals Returns Distribution Density
The distribution of Reata Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Reata Pharmaceuticals' future price movements. The chart of the probability distribution of Reata Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Reata Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Reata Pharmaceuticals returns is essential to provide solid investment advice for Reata Pharmaceuticals.
| Mean Return | 1.05 | Value At Risk | -2.91 | Potential Upside | 3.54 | Standard Deviation | 6.81 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Reata Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Disposition of 49701 shares by Michael Wortley of Reata Pharmaceuticals subject to Rule 16b-3 [view details]
Reata Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Reata . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Reata Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Reata Pharmaceuticals? Buying financial instruments such as Reata Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Reata Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Financials Thematic Idea Now
Financials
Companies that provide financial services to business or retail customers. The Financials theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Reata Stock
If you are still planning to invest in Reata Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reata Pharmaceuticals' history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |